Diversity of RH and transfusion support in Brazilian sickle cell disease patients with unexplained Rh antibodies

Carregando...
Imagem de Miniatura
Citações na Scopus
16
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
KELLY, Shannon
CASTILHO, Shirley L.
SCHIMIDT, Luciana C.
VALGUEIRO, Maria do C.
PREISS, Liliana R.
CUSTER, Brian
Citação
TRANSFUSION, v.59, n.10, p.3228-3235, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
BACKGROUND Genetic diversity in the RH genes among sickle cell disease (SCD) patients is well described but not yet extensively explored in populations of racially diverse origin. Transfusion support is complicated in patients who develop unexpected Rh antibodies. Our goal was to describe RH variation in a large cohort of Brazilian SCD patients exhibiting unexpected Rh antibodies (antibodies against RH antigens to which the patient is phenotypically positive) and to evaluate the impact of using the patient's RH genotype to guide transfusion support. STUDY DESIGN AND METHODS Patients within the Recipient Epidemiology and Evaluation Donor Study (REDS)-III Brazil SCD cohort with unexpected Rh antibodies were selected for study. RHD and RHCE exons and flanking introns were sequenced by targeted next-generation sequencing. RESULTS Fifty-four patients with 64 unexplained Rh antibodies were studied. The majority could not be definitively classified as auto- or alloantibodies using serologic methods. The most common altered RH were RHD*DIIIa and RHD*DAR (RHD locus) and RHCE*ce48C, RHCE*ce733G, and RHCE*ceS (RHCE locus). In 53.1% of the cases (34/64), patients demonstrated only conventional alleles encoding the target antigen: five of 12 anti-D (41.7%), 10 of 12 anti-C (83.3%), 18 of 38 anti-e (47.4%), and one of one anti-E (100%). CONCLUSION RHD variation in this SCD cohort differs from that reported for African Americans, with increased prevalence of RHD*DAR and underrepresentation of the DAU cluster. Many unexplained Rh antibodies were found in patients with conventional RH allele(s) only. RH genotyping was useful to guide transfusion to determine which patients could potentially benefit from receiving RH genotyped donor units.
Palavras-chave
Referências
  1. Carneiro-Proietti ABF, 2018, BRIT J HAEMATOL, V182, P895, DOI 10.1111/bjh.15462
  2. Casas J, 2015, TRANSFUSION, V55, P1388, DOI 10.1111/trf.12987
  3. Castilho L, 2005, TRANSFUSION MED, V15, P49, DOI 10.1111/j.1365-3148.2005.00548.x
  4. Chiu RWK, 2001, CLIN CHEM, V47, P667
  5. Chou ST, 2018, BLOOD, V132, P1198, DOI 10.1182/blood-2018-05-851360
  6. Chou ST, 2017, BLOOD ADV, V1, P1414, DOI 10.1182/bloodadvances.2017007898
  7. Chou ST, 2013, BLOOD, V122, P1062, DOI 10.1182/blood-2013-03-490623
  8. Dezan M. R., 2016, ISBT SCI SERIES, V11, P132
  9. Dezan MR, 2017, BLOOD CELL MOL DIS, V65, P8, DOI 10.1016/j.bcmd.2017.03.014
  10. Dinardo Carla Luana, 2013, Rev. Bras. Hematol. Hemoter., V35, P414, DOI 10.5581/1516-8484.20130123
  11. Gaspardi AC, 2016, BLOOD TRANSFUS-ITALY, V14, P449, DOI 10.2450/2016.0275-15
  12. Hendrickson JE, 2007, BLOOD, V110, P2736, DOI 10.1182/blood-2007-03-083105
  13. Hendrickson JE, 2012, TRANSFUSION, V52, P231, DOI 10.1111/j.1537-2995.2011.03255.x
  14. LaSalle-Williams M, 2011, TRANSFUSION, V51, P1732, DOI 10.1111/j.1537-2995.2010.03045.x
  15. Legler TJ, 2001, TRANSFUSION MED, V11, P383, DOI 10.1046/j.1365-3148.2001.00327.x
  16. Noizat-Pirenne F, 2011, TRANSFUS CLIN BIOL, V18, P527, DOI 10.1016/j.tracli.2011.09.001
  17. O'Suoji C, 2013, PEDIATR BLOOD CANCER, V60, P1487, DOI 10.1002/pbc.24530
  18. Arnoni CP, 2016, TRANSFUSION MED, V26, P285, DOI 10.1111/tme.12309
  19. Reid ME, 2014, BLOOD CELL MOL DIS, V52, P195, DOI 10.1016/j.bcmd.2013.11.003
  20. ROSSE WF, 1990, BLOOD, V76, P1431
  21. Sakhalkar VS, 2005, ANN NY ACAD SCI, V1054, P495, DOI 10.1196/annals.1345.072
  22. Silvy M, 2014, HAEMATOLOGICA, V99, DOI 10.3324/haematol.2014.104703
  23. Silvy M, 2011, BRIT J HAEMATOL, V154, P260, DOI 10.1111/j.1365-2141.2011.08691.x
  24. Smith NH, 2012, BLOOD, V119, P1566, DOI 10.1182/blood-2011-09-382655
  25. TAHHAN HR, 1994, TRANSFUSION, V34, P562, DOI 10.1046/j.1537-2995.1994.34794330008.x
  26. Tournamille C, 2010, TRANSFUSION, V50, P13, DOI 10.1111/j.1537-2995.2009.02382.x
  27. Vichinsky EP, 2001, TRANSFUSION, V41, P1086, DOI 10.1046/j.1537-2995.2001.41091086.x
  28. Wagner FF, 2002, BLOOD, V100, P306, DOI 10.1182/blood-2002-01-0320